Image_1_CO-Releasing Molecule (CORM)-3 Ameliorates Spinal Cord-Blood Barrier Disruption Following Injury to the Spinal Cord.tif
Spinal cord injury (SCI) is a clinical tough neurological problem without efficient cure currently. Blood-spinal cord barrier (BSCB) interruption is not only a crucial pathological feature for SCI process but is a possible target for future SCI treatments; however, few treatments have been developed to intervene BSCB. In the present study, we intravenously injected CO-releasing molecule3 (CORM-3), a classical exogenous CO donor, to the rats experiencing SCI and assessed its protection on BSCB integrity in rats. Our results demonstrated that the exogenous increasing of CO by CORM-3 blocked the tight junction (TJ) protein degeneration and neutrophils infiltration, subsequently suppressed the BSCB damage and improved the motor recovery after SCI. And we certified that the CO-induced down-regulation of MMP-9 expression and activity in neutrophil might be associated with the NF-κB signaling. Taken together, our study indicates that CO-releasing molecule (CORM)-3 ameliorates BSCB after spinal cord injury.
History
References
- https://doi.org//10.1002/ana.22421
- https://doi.org//10.1515/revneuro-2013-0046
- https://doi.org//10.1038/nm.4188
- https://doi.org//10.1097/00001756-200011090-00029
- https://doi.org//10.5483/BMBRep.2015.48.10.003
- https://doi.org//10.1038/jcbfm.2011.136
- https://doi.org//10.1016/j.nurt.2007.10.062
- https://doi.org//10.1146/annurev.pharmtox.010909.105600
- https://doi.org//10.1042/CS20110147
- https://doi.org//10.1016/j.addr.2003.10.043
- https://doi.org//10.1161/CIRCRESAHA.107.154781
- https://doi.org//10.1007/s12035-016-9910-6
- https://doi.org//10.1007/s12035-017-0509-3
- https://doi.org//10.1093/brain/aws171
- https://doi.org//10.1016/j.ajpath.2014.07.016
- https://doi.org//10.1016/j.redox.2018.07.001
- https://doi.org//10.1186/s12974-016-0521-y
- https://doi.org//10.1089/neu.2016.4608
- https://doi.org//10.1016/j.biopha.2017.10.092
- https://doi.org//10.3389/fphar.2018.00605
- https://doi.org//10.1038/nrd3228
- https://doi.org//10.1111/nyas.13922
- https://doi.org//10.1186/s12974-014-0150-2
- https://doi.org//10.1016/0006-8993(89)90542-8
- https://doi.org//10.1523/JNEUROSCI.22-17-07526.2002
- https://doi.org//10.1038/nm.3407
- https://doi.org//10.1038/74680
- https://doi.org//10.1016/j.nbd.2009.07.029
- https://doi.org//10.1159/000440982
- https://doi.org//10.1016/j.freeradbiomed.2014.02.020
- https://doi.org//10.1111/j.1471-4159.2007.04671.x
- https://doi.org//10.1111/bph.12729
- https://doi.org//10.1097/00004424-199702000-00006
- https://doi.org//10.1007/s00702-010-0514-4
- https://doi.org//10.1111/j.1600-0765.2010.01307.x
- https://doi.org//10.1523/JNEUROSCI.4918-08.2009
- https://doi.org//10.2147/DDDT.S19931
- https://doi.org//10.1161/CIRCULATIONAHA.109.905471
- https://doi.org//10.1016/j.freeradbiomed.2016.12.014
- https://doi.org//10.1186/s12974-018-1226-1
- https://doi.org//10.1097/WNR.0000000000000969
- https://doi.org//10.1523/JNEUROSCI.23-31-10107.2003
- https://doi.org//10.1016/j.freeradbiomed.2014.01.042
- https://doi.org//10.1089/neu.2007.0438
- https://doi.org//10.1007/s12640-009-9014-4
- https://doi.org//10.1007/s00395-017-0603-8
- https://doi.org//10.1111/jcmm.13235
- https://doi.org//10.1016/j.ebiom.2018.12.059
CC BY 4.0